| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/25/2007 | CN101002613A Health-care nutrient rice, and its production process |
| 07/25/2007 | CN101002610A Pumpkin powder, and its production method |
| 07/25/2007 | CN101002608A Food adjuvant made of natto product and preserved fruit, and processing method therefor |
| 07/25/2007 | CN101002600A Method for producing high gluten granule made from corn |
| 07/25/2007 | CN101002598A Art for producing milk production increasing agent by utilizing earth-worm extractive as raw material |
| 07/25/2007 | CN101002576A Noodles containing Xuelianguo, and its preparing method |
| 07/24/2007 | US7247746 Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
| 07/24/2007 | US7247705 Proteins having glucose transporter activity |
| 07/24/2007 | US7247633 Pyrimidine compounds and their use |
| 07/24/2007 | US7247630 Nitrogen compounds such as 3-(5-hydroxyhexyl)-1-methyl-1H-imidazo(2,1-f)purine-2,4(3H,6H)-dione, used for prophylaxis of diseases associated with cytokine intracellular signal transduction |
| 07/24/2007 | US7247624 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 07/24/2007 | US7247616 Pyrazole derivatives and diabetic medicine containing them |
| 07/24/2007 | US7247328 Chromium (III) alpha amino acid complexes |
| 07/24/2007 | CA2097185C Viral recombinant vectors for expression in muscle cells |
| 07/19/2007 | WO2007081091A1 Rhodandse derivarives, a process for the preparation thereof and pharmaceutical composition containing the same |
| 07/19/2007 | WO2007081031A1 Glycosyltransferase inhibitor |
| 07/19/2007 | WO2007080787A1 Coenzyme q10-containing water-soluble compositions |
| 07/19/2007 | WO2007080170A1 CRYSTALLINE FORM OF 1´-(1-METHYLETHYL)- 4´-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5´-METHYL-1H-PYRAZOL-3´-O-β-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 07/19/2007 | WO2007079914A2 Combination of triazine derivatives and insulin secretion stimulators |
| 07/19/2007 | WO2007079681A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 07/19/2007 | WO2007041052B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/19/2007 | WO2007031333A3 Improvements in or relating to amphoteric liposomes |
| 07/19/2007 | WO2006131326A3 Novel use of (-)-epigallocatechin gallate |
| 07/19/2007 | WO2006128083A3 Human proislet peptide, derivatives and analogs thereof, and methods of using same |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070167512 Lipid metabolism improving agent |
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 07/19/2007 | US20070167483 Phenylalanine Enamide Derivatives |
| 07/19/2007 | US20070167461 USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a] PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070166413 Cholestrol-reducing agent containing an n-3 fatty acid |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | US20070164009 Processing method and processing device |
| 07/19/2007 | DE102005057178A1 Verwendung von Zinksalzen der Liponsäure zur Behandlung von Fettstoffwechselstörungen Use of zinc salts of lipoic acid in the treatment of dyslipidemia |
| 07/19/2007 | CA2636837A1 Combination of triazine derivatives and insulin secretion stimulators |
| 07/19/2007 | CA2635203A1 Crystalline form of 1´-(1-methylethyl)- 4´-[(2-fluoro-4-methoxyphenyl)methyl]-5´-methyl-1h-pyrazol-3´-o-.beta.-d-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
| 07/18/2007 | EP1808484A1 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/18/2007 | EP1808176A2 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation |
| 07/18/2007 | EP1808175A1 Drugs, food or drink for improving pancreatic functions |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1808168A1 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 07/18/2007 | EP1808078A1 Modified coffee, method of roasting coffee bean, coffee-like supplement and auxiliary food |
| 07/18/2007 | EP1807429A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/18/2007 | EP1807428A2 Process for preparing quinoline compounds and products obtained therefrom |
| 07/18/2007 | EP1807411A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 07/18/2007 | EP1807409A2 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 07/18/2007 | EP1807408A1 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 07/18/2007 | EP1807398A1 New indole or benzimidazole derivatives |
| 07/18/2007 | EP1807390A2 Arylalkyl ureas as cb1 antagonists |
| 07/18/2007 | EP1807105A2 Insulin receptor binding peptides with non-insulin gene activation profiles and uses thereof |
| 07/18/2007 | EP1807099A2 Y2 selective receptor agonists for therapeutic interventions |
| 07/18/2007 | EP1807089A1 Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mamal and compositions containing the same |
| 07/18/2007 | EP1807085A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/18/2007 | EP1807072A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/18/2007 | EP1807070A1 Combinations of substituted azetidinones and cb1 antagonists |
| 07/18/2007 | EP1807069A1 Methods for regulating weight and size of animals with glycine |
| 07/18/2007 | EP1807066A1 Combination of dpp-iv inhibitor, ppar antidiabetic and metformin |
| 07/18/2007 | EP1807063A2 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 07/18/2007 | EP1711184B1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/18/2007 | EP1603912B1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 07/18/2007 | EP1583547A4 Anti-obesity ingretients from medicinal plants and their composittion |
| 07/18/2007 | EP1525204B1 Phenylalanine enamide derivatives |
| 07/18/2007 | EP1508566B1 (2s)-2-ethylphenylpropionic acid derivative |
| 07/18/2007 | EP1497436B1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 07/18/2007 | EP1377280B1 Use of bulking agents as satiety agents |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1278513B1 A core formulation |
| 07/18/2007 | EP1181043B1 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 07/18/2007 | EP1180097B1 Mutual salt of amlodipine and atorvastatin |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | CN1326876C Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/18/2007 | CN1326863C New type azesaccharide compound, their synthesis method and use as immune inhibitor and glycocidase inhibitor |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN1326848C Aminopyrazole derivatives |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/18/2007 | CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 07/18/2007 | CN1326561C Remedies for liver diseases, hyperlipemia and diabetes |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN1326531C Health care tea for preventing cancer, lowering blood fat and lowering blood pressure |
| 07/18/2007 | CN1326529C Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001854A Highly selective novel amidation method |
| 07/18/2007 | CN101001841A Tetrahydroquinolones and aza-analogues thereof for use as DPP-IV inhibitors in the treatement of diabetes |
| 07/18/2007 | CN101001838A DPP-IV inhibitors |
| 07/18/2007 | CN101001837A Indole derivatives comprising an acetylene group as PPAR activators |
| 07/18/2007 | CN101001836A Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/18/2007 | CN101001624A Compositions comprising flavonoids and tocotrienols and methods thereof |
| 07/18/2007 | CN101001620A Use of alpha-ketoglutarate and related compounds for lowering plasma lipids |
| 07/18/2007 | CN101001619A Combination of bupropion and a second compound for affectingweight loss |
| 07/18/2007 | CN100999616A Preparation process of squid ink black pigment and application thereof |
| 07/18/2007 | CN100999546A Polypeptide compound with aza-containing heterocyclic modified and its application |
| 07/18/2007 | CN100999536A Process of simultaneously extracting and detecting cornus cyclic olefine ether terpinyl side like extractive |
| 07/18/2007 | CN100999517A Pyrazole formylamine derivate, its pharmaceutical composition and preparation process |
| 07/18/2007 | CN100999496A Compound of polyphenols with aza-containing heterocyclic modified and use thereof |
| 07/18/2007 | CN100999471A Production tech. of acid type lovastatin and production tech of its salt and pharmaceutical application |